Receptor activity modifying protein-directed G protein signaling specificity for the calcitonin gene-related peptide family of receptors

Article, Other literature type English OPEN
Weston, Cathryn ; Winfield, Ian ; Harris, Matthew ; Hodgson, Rose ; Shah, Archna ; Dowell, Simon J ; Mobarec, Juan Carlos ; Woodlock, David A ; Reynolds, Christopher A ; Poyner, David R ; Watkins, Harriet A ; Ladds, Graham Robert (2016)
  • Publisher: The Journal of Biological Chemistry
  • Journal: volume 291, issue 42, pages 21,925-21,944 (issn: 0021-9258, eissn: 1083-351X)
  • Related identifiers: doi: 10.1074/jbc.A116.751362, doi: 10.17863/CAM.6014, doi: 10.1074/jbc.M116.751362, pmc: PMC5063977
  • Subject: Additions and Corrections | adrenomedullin | G protein-coupled receptors (GPCRs) | signal transduction | molecular modelling | adrenomedullin 2 | RAMP | molecular dynamics | CGRP | G protein-coupled receptor (GPCR) | yeast | signal bias | molecular modeling | receptor activity modifying proteins (RAMPs)

The calcitonin gene-related peptide (CGRP) family of G protein-coupled receptors (GPCRs) is formed through association of the calcitonin receptor-like receptor (CLR) and one of three receptor activitymodifying proteins (RAMPs). Binding of one of the three peptide ligands, CGRP, adrenomedullin (AM) or intermedin/adrenomedullin2 (AM2) is well known to result in a Gαs-mediated increase in cAMP. Here we use modified yeast strains that couple receptor activation to cell growth, via chimeric yeast/Gα subunits, and HEK-293 cells to characterize the effect of different RAMP and ligand combinations on this pathway. We not only demonstrate functional couplings to both Gα$_{s}$ and Gα$_{q}$ but also identify a Gα$_{i}$ component to CLR signaling in both yeast and HEK- 293 cells, which is absent in HEK-293S cells. We show that the CGRP family of receptors displays both ligand and RAMP-dependent signaling bias between Gα$_{s}$, Gα$_{i}$ and Gα$_{q/11}$ pathways. The results are discussed in the context of RAMP interactions probed through molecular modelling and molecular dynamics simulations of the RAMP-GPCR-G protein complexes. This study further highlights the importance of RAMPs to CLR pharmacology, and to bias in general, as well as identifying the importance of choosing an appropriate model system for the study of GPCR pharmacology. This work was supported by the National Heart Foundation of New Zealand (H.W.), the School of Biological Sciences, University of Auckland seed fund (H.W.), the BBSRC (G.L. - BB/M00015X/1), (D.P. - BB/M000176/1), (C.A.R. - BB/M006883/1), a BBSRC Doctoral Training Partnership (M.H. – BB/JO14540/1), an MRC Doctoral Training Partnership (I.W. - MR/J003964/1), a Warwick Impact Fund (C.W., G.L.), a Warwick Research Development Fund (C.W., G.L.) grant number (RD13301) and the Warwick Undergraduate Research Scholarship Scheme (A.S and R.H). This is the author accepted manuscript. It is currently under an indefinite embargo pending publication by the American Society for Biochemistry and Molecular Biology.
  • References (72)
    72 references, page 1 of 8

    1. Hong, Y., Hay, D. L., Quirion, R., and Poyner, D. R. (2012) The pharmacology of adrenomedullin 2/intermedin. Br. J. Pharmacol. 166, 110 -120

    2. Russell, F. A., King, R., Smillie, S. J., Kodji, X., and Brain, S. D. (2014) Calcitonin gene-related peptide: physiology and pathophysiology. Physiol. Rev. 94, 1099 -1142

    3. Edvinsson, L., and Warfvinge, K. (2013) CGRP receptor antagonism and migraine therapy. Curr. Protein Pept. Sci. 14, 386 -392

    4. Kato, J., and Kitamura, K. (2015) Bench-to-bedside pharmacology of adrenomedullin. Eur. J. Pharmacol. 764, 140 -148

    5. Fritz-Six, K. L., Dunworth, W. P., Li, M., and Caron, K. M. (2008) Adrenomedullin signaling is necessary for murine lymphatic vascular development. J. Clin. Invest. 118, 40 -50

    6. Ichikawa-Shindo, Y., Sakurai, T., Kamiyoshi, A., Kawate, H., Iinuma, N., Yoshizawa, T., Koyama, T., Fukuchi, J., Iimuro, S., Moriyama, N., Kawakami, H., Murata, T., Kangawa, K., Nagai, R., and Shindo, T. (2008) The GPCR modulator protein RAMP2 is essential for angiogenesis and vascular integrity. J. Clin. Invest. 118, 29 -39

    7. Roh, J., Chang, C. L., Bhalla, A., Klein, C., and Hsu, S. Y. (2004) Intermedin is a calcitonin/calcitonin gene-related peptide family peptide acting through the calcitonin receptor-like receptor/receptor activity-modifying protein receptor complexes. J. Biol. Chem. 279, 7264 -7274

    8. Holmes, D., Campbell, M., Harbinson, M., and Bell, D. (2013) Protective effects of intermedin on cardiovascular, pulmonary and renal diseases: comparison with adrenomedullin and CGRP. Curr. Protein Pept. Sci. 14, 294 -329

    9. Takei, Y., Inoue, K., Ogoshi, M., Kawahara, T., Bannai, H., and Miyano, S. (2004) Identification of novel adrenomedullin in mammals: a potent cardiovascular and renal regulator. FEBS Lett. 556, 53-58

    10. Smillie, S. J., and Brain, S. D. (2011) Calcitonin gene-related peptide (CGRP) and its role in hypertension. Neuropeptides 45, 93-104

  • Metrics
    No metrics available